The effectiveness of the use of flavonoids in the complex treatment of psoriasis in patients with grade I-II alimentary obesity

dc.contributor.authorYemchenko, Ya.
dc.contributor.authorVasylieva, K.
dc.contributor.authorBezeha, O.
dc.contributor.authorЄмченко, Яна Олександрівна
dc.contributor.authorВасильєва, Катерина Володимирівна
dc.contributor.authorБезега, Олена Вікторівна
dc.date.accessioned2020-11-16T08:03:04Z
dc.date.available2020-11-16T08:03:04Z
dc.date.issued2020
dc.description.abstractPsoriasis is one of the chronic dermatoses with unexplained pathogenesis and significant prevalence among the population. Chronic and often severe course of the disease leads to disability, and sometimes to disability [1]. The lack of a clear understanding of the etiology and pathogenesis makes it possible to attribute this dermatosis to the most important medical and economic health problems [8]. It is believed that psoriasis refers to genetically determined diseases with predominant skin damage, which is associated with impaired keratinocyte proliferation and the development of inflammatory processes [2]. An undoubted relationship between psoriasis and obesity has been established [3]. In the literature, the question of identical pathogenetic mechanisms of inflammatory processes in psoriasis and obesity, forming a vicious circle at the level of the immune system, which must be broken for the successful treatment of these diseases, is widely covered [4]. Obesity can be either an independent multifactorial disease - primary obesity (alimentary-constitutional), or the syndrome accompanying the course of other diseases - secondary obesity (symptomatic). In the structure of morbidity, primary obesity occurs in 95% of patients, secondary - only in 5% [7,9]. A person is considered obese if the body mass index (BMI) exceeds 30 kg / m². According to the results of previous studies, we found that alimentary obesity in patients with psoriasis leads to metabolic disorders complicating the course of dermatosis, leading to the ineffectiveness of standard methods of therapy and frequent exacerbations of psoriatic disease [5].uk_UA
dc.identifier.citationYemchenko Ya. The effectiveness of the use of flavonoids in the complex treatment of psoriasis in patients with grade I-II alimentary obesity / Ya. Yemchenko, K. Vasylieva, O. Bezeha // The ХХIII th International scientific and practical conference «Theoretical and practical foundations of social process management», San Francisco, June, 29–30, 2020. – San Francisco, 2020. – P. 118–124.uk_UA
dc.identifier.doi10.46299/ISG.2020.XXIII
dc.identifier.isbn978-1-64871-431-3
dc.identifier.urihttp://isg-konf.com
dc.identifier.urihttps://repository.pdmu.edu.ua/handle/123456789/13935
dc.language.isoenuk_UA
dc.publisherInternational Science Groupuk_UA
dc.relation.ispartofseriesUDK;01.1
dc.subjectpsoriasisuk_UA
dc.subjectalimentary obesityuk_UA
dc.subjectflavonoidsuk_UA
dc.subjectPASIuk_UA
dc.subjectresveratroluk_UA
dc.subjectrutinuk_UA
dc.subjectsilymarinuk_UA
dc.subject.udc01.1uk_UA
dc.titleThe effectiveness of the use of flavonoids in the complex treatment of psoriasis in patients with grade I-II alimentary obesityuk_UA
dc.typeThesisuk_UA

Файли

Контейнер файлів
Зараз показуємо 1 - 1 з 1
Ескіз недоступний
Назва:
TheeffectivenessoftheuseofflavonoidsinthecomplextreatmentofpsoriasisinpatientswithgradeI_IIalimentaryobesity.pdf
Розмір:
288.24 KB
Формат:
Adobe Portable Document Format
Опис:
Ліцензійна угода
Зараз показуємо 1 - 1 з 1
Ескіз недоступний
Назва:
license.txt
Розмір:
4.29 KB
Формат:
Item-specific license agreed upon to submission
Опис: